AI Assistant
Blog
Pricing
Log In
Sign Up
343 A benefit-risk assessment of daridorexant for the treatment of insomnia using patient preference data from two phase 3 trials
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.